bioAffinity Technologies, Inc. (BIAF)
2.03
-0.09
(-4.25%)
USD |
NASDAQ |
May 08, 16:00
2.02
-0.01
(-0.49%)
After-Hours: 20:00
bioAffinity Technologies Total Assets (Quarterly) : 7.945M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Veracyte, Inc. | 1.436B |
| Insight Molecular Diagnostics, Inc. | 25.76M |
| Exagen, Inc. | 59.20M |
| GRAIL, Inc. | 2.803B |
| FONAR Corp. | 217.22M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 4.284M |
| Shareholders Equity (Quarterly) | 3.661M |
| Debt to Equity Ratio | 0.3776 |
| Current Ratio | 1.363 |
| Net Debt Paydown Yield | 0.14% |